BNGO
Bionano Genomics Inc
NASDAQ: BNGO · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$1.16
-2.52% today
Updated 2026-04-29
Market cap
$13.42M
P/E ratio
—
P/S ratio
0.47x
EPS (TTM)
$-4.85
Dividend yield
—
52W range
$1 – $6
Volume
0.3M
Bionano Genomics Inc (BNGO) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | $14.79M | $10.15M | $24.80M | $30.21M | $60.45M | $377.10M | $307.50M | $214.40M | $76.67M |
| Cash & equivalents | $5.25M | $1.02M | $16.52M | $17.31M | $38.45M | $24.57M | $5.09M | $17.95M | $9.17M |
| Current assets | $10.74M | $7.14M | $23.03M | $28.26M | $46.79M | $272.41M | $157.30M | $140.12M | $39.49M |
| Total liabilities | $42.05M | $60.37M | $14.67M | $26.59M | $25.37M | $39.98M | $58.10M | $118.25M | $41.30M |
| Current liabilities | $9.36M | $16.65M | $4.52M | $26.37M | $8.94M | $21.84M | $35.88M | $100.03M | $37.34M |
| Long-term debt | $6.05M | — | $9.03M | — | $16.33M | — | — | — | — |
| Shareholder equity | $-27.26M | $-50.23M | $10.14M | $3.61M | $35.08M | $337.12M | $249.40M | $96.16M | $35.38M |
| Retained earnings | $-30.90M | $-54.27M | $-72.76M | $-102.58M | $-143.68M | $-216.12M | $-348.71M | $-581.21M | $-693.23M |
| Accounts receivable | $1.85M | $3.35M | $4.51M | $6.33M | $2.78M | $5.32M | $7.50M | $9.66M | $4.77M |
| Inventory | $1.80M | $1.69M | $1.07M | $3.44M | $3.32M | $12.39M | $29.76M | $22.89M | $11.12M |
| Goodwill | — | — | — | — | $7.17M | $56.16M | $77.29M | $0.00 | — |